GLAND PHARMA
|
The Current P/S Ratio of GLAND PHARMA is 5.81.
Share Price | ₹2,015.4 | Sep 15,2025 |
Market Cap | ₹33,213.8 Cr | |
Sales-TTM | ₹5,720.4 Cr | TTM-Consolidated Results |
Price/Sales | 5.81x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹33,213.8 Cr] as on Sep 15,2025
(/) Sales [ ₹5,720.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.81x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay '5.81 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAND PHARMA !
The chart below summarizes the trend in P/S Ratio of GLAND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of GLAND PHARMA
PS Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.94x.
- GLAND PHARMA 's operated at median p/e ratio of 5.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 12.21x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2025 of 4.67x.
How does GLAND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAND PHARMA | 5,720.4 | 5.81 | 33,213.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.15 | 384,469.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.65 | 160,672.0 |
CIPLA LTD | 27,811.2 | 4.50 | 125,034.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.10 | 119,542.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.24 | 108,571.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.23 | 106,634.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.42 | 104,316.0 |
LUPIN LTD | 23,375.9 | 4.00 | 93,490.8 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.99 | 63,809.8 |
ABBOTT INDIA LTD | 6,589.9 | 9.97 | 65,714.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.99x |
Max industry PS | 16.65x |
Median industry PS | 5.81x |
Average industry PS | 6.91x |
You may also like the below Video Courses